Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-05T04:34:42.216Z Has data issue: false hasContentIssue false
  • English
  • Français

Ischemic Neuronal Injury is Ameliorated by Astrocyte Activation

Published online by Cambridge University Press:  18 September 2015

Deon F. Louw ,
Tetsuy Masada  and
Garnette R. Sutherland
Deon F. Louw
Affiliation:
Department of Clinical Neurosciences, The University of Calgary, Calgary, Canada
Tetsuy Masada
Affiliation:
Department of Neurological Surgery and Physiology, Kagawa Medical School, Kagawa, Japan
Garnette R. Sutherland*
Affiliation:
Department of Clinical Neurosciences, The University of Calgary, Calgary, Canada
*
75 Bruyere Street, Ottawa, Ontario, Canada K1N 5C8
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

The motivation of this study was to more precisely define the in vivo role of astrocytes in forebrain ischemia. Controversy exists in the literature as to whether they protect or injure neurons in this setting.

Methods:

Astrocytes in the rat hippocampus were disabled with stereotactic administration of a gliotoxin, ethidium bromide, 3 days prior to induction of forebrain ischemia. The extent of neuronal injury in this group was compared to a control category receiving intrahippocampal saline only.

Results:

Saline-injected animals demonstrated decreased hippocampal CA1 sector injury, and increased gliosis on the side of the injection compared to the contralateral side (P < 0.01) or ethidium bromide-treated animals (P < 0.05).

Conclusion:

The results suggest that activated astrocytes are protective to neurons subjected to an ischemic insult. This may result from their ability to elaborate neurotrophic factors, buffer potassium and metabolize a variety of neurotransmitters.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 25 , Issue 2 , February 1998 , pp. 102 - 107
Copyright
Copyright © Canadian Neurological Sciences Federation 1998

References

REFERENCES

1.Swanson, RA. Astrocyte glutamate uptake during chemical hypoxia in vitro. Neurosci Lett 1992; 147: 143–146.CrossRefGoogle ScholarPubMed
2.Walz, W. Role of glial cells in the regulation of the brain microenvironment. Prog Neurobiol 1989; 33: 309–333.CrossRefGoogle Scholar
3.Walz, W, Mukerji, S. Simulation of aspects of ischemia in cell culture: changes in lactate compartmentation. Glia 1990; 3: 522–528.CrossRefGoogle ScholarPubMed
4.Barres, BA. New roles for glia. J Neurosci 1991; 11: 3685–3694.CrossRefGoogle ScholarPubMed
5.Murphy, S, Minor, RL, Welk, G, Harrison, DG. Evidence for an astrocyte-derived vasorelaxing factor with properties similar to nitric oxide. J Neurochem 1990; 55: 349–351.CrossRefGoogle ScholarPubMed
6.Newman, EA, Frambach, DA, Odette, LL. Control of extracellular potassium levels by retinal glial cell K siphoning. Science 1984; 225: 1174–1175.CrossRefGoogle ScholarPubMed
7.Parpura, V, Basarsky, TA, Liv, F, et al. Glutamate-mediated astrocyte-neuron signalling. Nature 1994; 369: 744–747.CrossRefGoogle ScholarPubMed
8.Diedrich, JF, Bendheim, PE, Kim, YS, et al. Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc Nat Acad Sci U.S.A. 1991; 88: 375–379.CrossRefGoogle ScholarPubMed
9.Eddelstone, M, Mucke, L. Molecular profile of reactive astrocytes – implications for their role in neurologic disease. Neuroscience 1993; 54: 15–36.CrossRefGoogle Scholar
10.De Le Monte, SM, Ho, DD, Schooley, RT, et al. Subacute encephalomyelitis of AIDS and its relation to the HTLV-III infection. Neurology 1987; 37: 562–569.CrossRefGoogle Scholar
11.Petito, CK, Morgello, S, Felix, JC, Lesser, ML. The two patterns of reactive astrocytosis in post ischemic rat brain. J Cereb Blood Flow Metab 1990; 10: 850–859.CrossRefGoogle Scholar
12.Mucke, L, Oldstone, MBA, Morris, JC, Nerenberg, MI. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol 1991; 3: 465–474.Google ScholarPubMed
13.Ogata, T, Nakamura, Y, Shibata, T, Kataoka, K. Release of excitatory aminoacids from cultured hippocampal astrocytes induced by a hypoxic-hypoglycemic stimulation. J Neurochem 1992; 58: 1957–1959.CrossRefGoogle ScholarPubMed
14.Bednar, NN, Kohut, JJ, Kimelberg, HK, et al. In vitro evidence supporting two mechanisms of action for the anion transport inhibitor L-644,711 in cerebral ischemia.Neurol Res 1992; 14: 53–56.CrossRefGoogle Scholar
15.Blakemore, WF. Ethidium bromide induced demyelination in the spinal cord of the cat. Neuropathol Appl Neurobiol 1982; 8: 365–375.CrossRefGoogle ScholarPubMed
16.Luvisotto, TL, Auer, RN, Sutherland, GR. The effect of mannitol on experimental cerebral ischemia, revisited. Neurosurgery 1996; 38: 131–139.CrossRefGoogle ScholarPubMed
17.Sutherland, GR, Peeling, J, Lesiuk, HJ, et al. The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology. Neuroscience 1991; 42: 171–182.CrossRefGoogle ScholarPubMed
18.Sutherland, G, Lesiuk, H, Bose, R, Sima, AAF. Effect of mannitol, nimodipime, and indomethacin singly or in combination on cerebral ischemia in rats. Stroke 1988; 19: 571–578.CrossRefGoogle ScholarPubMed
19.Hsu, SM. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody PAP procedures. J Histochem Cytochem 1981; 29: 577–580.CrossRefGoogle ScholarPubMed
20.Sternberger, LA. The unlabelled antibody enzyme method of immunohistochemistry. J Histochem Cytochem 1970; 13: 315–333.CrossRefGoogle Scholar
21.Kraig, KP, Chester, M. Astrocytic acidosis in hyperglycemic and complete ischemia. J Cereb Blood Flow Metab 1990; 10: 104–114.CrossRefGoogle Scholar
22.Norten, WT, Cammer, W, Bloom, BR, Gordon, S. Neutral proteinases secreted by macrophages degrade basic protein: a possible mechanism of inflammatory demyelination. In: Palo, J, ed. Myelination and Demyelination. New York: Plenum Press, 1978, 365–381.CrossRefGoogle Scholar
23.Guilian, D. Reactive glia as rivals in regulating neuronal survival. Glia 1993; 7: 102–110.CrossRefGoogle Scholar
24.Nieto-Sampedro, , Lewis, ER, Cotman, CW, et al. Brain injury causes a time-dependent increase in neurotrophic activity at the lesion site. Science 1982; 217: 860–861.CrossRefGoogle Scholar
25.Cheng, B, Mattson, MP. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilising calcium homeostasis. Neuron 1991; 7: 1031–1041.CrossRefGoogle ScholarPubMed
26.Koketsu, N, Berlove, DJ, Moskowitz, MA, et al. Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats. Ann Neurol 1994; 35: 451–457.CrossRefGoogle ScholarPubMed
27.Mattson, MP, Murrain, M. Guthrie, PB, Kater, SB. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J Neurosci 1989; 9: 3728–3740.CrossRefGoogle ScholarPubMed
28.Pettman, B, Weibel, M, Sensenbrenner, M, Labourdette, G. Purification of two astroglial growth factors from bovine brain. FEBS Lett 1985; 189: 102–108.CrossRefGoogle Scholar
29.Lin, RCS, Polsky, K, Matesic, DF. Expression of γ-aminobutyric acid immunoreactivity in reactive astrocytes after ischemia-induced injury in the adult forebrain. Brain Res 1993; 600: 1–8.CrossRefGoogle ScholarPubMed
30.Sutherland, GR, Bose, R, Louw, D, Pinsky, C. Global elevation of brain superoxide dismutase activity following forebrain ischemia in rat. Neurosci Lett 1991; 128: 169–172.CrossRefGoogle ScholarPubMed
31.Norenberg, MD. Immunohistochemistry of glutamine synthetase. In: Hertz, L, ed. Glutamine, Glutamate, and GABA in the Central Nervous System. New York: A.R. Liss, 1983: 95–111.Google Scholar
32.Petito, CK, Babiak, T. Early proliferative changes in astrocytes in postischemic noninfarcted rat brain. Ann Neurol 1982; 11: 510–518.CrossRefGoogle ScholarPubMed